TVM Capital Healthcare Invests $35M in Boston Oncology Arabia
TVM Capital Healthcare has announced a USD 35 million investment in Boston Oncology Arabia, a bio-generic drugs manufacturer based in Saudi Arabia. Headquartered in Riyadh with a production facility in…
Technology Holdings advises Design + Industry on sale to Capgemini
Technology Holdings, a global investment bank with offices in North America, Europe, and Asia-Pacific, has acted as the exclusive financial advisor to Design + Industry in its strategic sale to…
Flow Cytometry & Extracellular Vesicles 2024 Conference: Laguna Hills, USA – Nov 18-20
ResearchAndMarkets.com is pleased to announce the addition of the “Innovations in Flow Cytometry & Extracellular Vesicles 2024” conference to its offerings. Bringing together researchers and industry participants from academia and…
Xeno Biosciences Launches Phase 1b Study for Obesity Proof-of-Concept
Xeno Biosciences Inc., a company focused on advancing therapies for obesity and metabolic diseases, has initiated a Phase 1b clinical study to evaluate the efficacy, safety, and tolerability of its…
Takeda Reveals Phase 2b Study Data on Mezagitamab in Primary Immune Thrombocytopenia
Takeda (TSE:4502/NYSE) unveiled encouraging findings from its Phase 2b study, which evaluated mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare bleeding disorder caused by…
Insights: U.S. EMR Market 2024-2029 with Epic Systems, Oracle, eClinicalWorks, MEDITECH, Veradigm
The “U.S. Electronic Medical Records (EMR) Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. Post this:The U.S. Electronic Medical Records (EMR) Market reached USD 5.92 billion…
Alcon’s Unity VCS and Unity CS Cleared by FDA
Alcon (SIX/NYSE: ALC), a global leader in eye care, has received U.S. FDA 510(k) clearance for its UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS). These advancements mark…
Cerus Corporation Presents at 38th ISBT Congress
Cerus Corporation (Nasdaq) announced today its participation in the 38th International Congress of the International Society of Blood Transfusion (ISBT) in Barcelona, Spain, from June 23 to June 27. This…
Bristol Myers Squibb Announces KRAZATI® for KRAS G12C-Mutated CRC
“Bristol Myers Squibb (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRAZATI® (adagrasib) in combination with cetuximab as a targeted treatment…
ALS Therapy Development Institute Maps Clinical Trials with Esri Technology
The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech firm dedicated to eliminating amyotrophic lateral sclerosis (ALS), has leveraged Esri’s mapping technology to introduce the ALS Trial Navigator. This…
Insulet’s Omnipod® 5 Enhances Outcomes in Type 2 Diabetes: SECURE-T2D Trial Results
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology under the Omnipod® brand, has unveiled positive outcomes from its pivotal trial of the Omnipod 5 Automated Insulin Delivery…
OrsoBio to Unveil Liver-Targeted TLC-6740 Data at ADA’s 84th Scientific Sessions
OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on treatments for obesity and associated disorders, has unveiled new data for its liver-targeted mitochondrial protonophore, TLC-6740, at the 84th Scientific Sessions of…